These two ERα‐H3K4me1‐gene modules allow breast cancer cells with a loss in functional MLL3 to increase the expression of canonical ERα targets, while also deploying transcriptional programs shown to mediate aggressive tumor behaviors. This evidence concerns the gene ESR1 and breast carcinoma.